Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyThoracic TumorsTumor, regardless of entityUrologic OncologyDiseaseBreast CancerLung Carcinoma, Non-Small CellLung Carcinoma, Small CellRenal Cell CarcinomaTumor, Various OrgansSubgroupICD10C34.-C50.-C64MeSHBreast NeoplasmsCarcinoma, Renal CellKidney NeoplasmsNeoplasmsSmall Cell Lung CarcinomaSequenceChemotherapyChemo-substanceCisplatinHydrocortisoneLenvatinibMitoxantronePembrolizumabThiotepaChemo-substanceCisplatinHydrocortisoneLenvatinibMitoxantronePembrolizumabThiotepaChemo-substanceCisplatinHydrocortisoneLenvatinibMitoxantronePembrolizumabThiotepaChemo-substanceCisplatinHydrocortisoneLenvatinibMitoxantronePembrolizumabThiotepaNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionSupportive substanceBalanced Crystalloid SolutionSupportive substanceBalanced Crystalloid SolutionSupportive substanceBalanced Crystalloid SolutionNo. Substances1Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksAdrenal InsufficiencyArthalgiaCardiotoxicityColitisDiarrheaEmetogenicityEmetogenicity (ASCO)Emetogenicity (MASCC/ESMO)HypertensionHypomagnesemiaHyponatremiaHypothyroidismLeukopeniaPancreatitisPneumonitisProteinuriaRenal FailureThrombocytopenia below 50 000/µlThromboembolic Event only studiesPublicationAuthorMaisch BMartinoni A Musch ETaylor MHDiseaselokal fortgeschrittener oder metastasierter Tumor, unabhängig von der Entität, progredient nach 2 oder weniger Therapielinien, ECOG 0-1Maligner Perikarderguss, hämodynamisch relevantOriginAllgemeine Innere Medizin, Marienhospital Bottrop, GermanyCardiology Unit, Milan, ItalyDepartment of Internal Medicine-Cardiology, Philipps University, Marburg, GermanyKnight Cancer Institute, Oregon Health and Science University, Portland, USAProtocols in Revision 4 protocols foundProtocols under revision.Cisplatin 30, Tumor, Various Organs (PID2371 V1.0)Lenvatinib 20 / Pembrolizumab 200, Tumor, Various Organs (PID1518 V1.0)Mitoxantrone 20, Tumor, Various Organs (PID2370 V1.0)Thiotepa 15 / Hydrocortisone 30, Tumor, Various Organs (PID2372 V1.0)
